ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,631,538 | -10.9% | 134,377 | +1.3% | 0.00% | 0.0% |
| Q2 2023 | $4,074,400 | +349.7% | 132,695 | +428.6% | 0.00% | +300.0% |
| Q1 2023 | $906,003 | -97.0% | 25,104 | -96.8% | 0.00% | -97.1% |
| Q4 2022 | $30,270,660 | +60.3% | 775,177 | +66.2% | 0.04% | +12.9% |
| Q3 2022 | $18,885,000 | +92.3% | 466,526 | +99.4% | 0.03% | +121.4% |
| Q2 2022 | $9,821,000 | +927.3% | 233,992 | +794.3% | 0.01% | +1300.0% |
| Q3 2021 | $956,000 | +36.6% | 26,164 | +54.4% | 0.00% | 0.0% |
| Q2 2021 | $700,000 | -22.1% | 16,947 | -7.6% | 0.00% | 0.0% |
| Q4 2020 | $899,000 | +247.1% | 18,341 | +204.0% | 0.00% | – |
| Q3 2020 | $259,000 | – | 6,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |